tiprankstipranks
Denali Therapeutics (DNLI)
NASDAQ:DNLI
US Market
DNLI
Denali Therapeutics
RESEARCH TOOLSreports

Denali Therapeutics (DNLI) Stock News & Sentiment

877 Followers
Denali Therapeutics: Differentiated PGRN Strategy and AVLAYAH Strength Support Buy Rating and Higher $39 Target Despite Biology Risks
Premium
Ratings
Denali Therapeutics: Differentiated PGRN Strategy and AVLAYAH Strength Support Buy Rating and Higher $39 Target Despite Biology Risks
6d ago
DNLI
Denali Regains DNL593 Rights After Takeda Collaboration Ends
Premium
Company Announcements
Denali Regains DNL593 Rights After Takeda Collaboration Ends
9d ago
8K
DNLI
Denali Therapeutics Secures $200 Million Royalty Funding
Premium
Company Announcements
Denali Therapeutics Secures $200 Million Royalty Funding
12d ago
8K
DNLI
Denali Therapeutics: AVLAYAH’s Superior Efficacy, BBB Shuttle Platform, and Robust Pipeline Support Buy Rating and Higher Target
Premium
Ratings
Denali Therapeutics: AVLAYAH’s Superior Efficacy, BBB Shuttle Platform, and Robust Pipeline Support Buy Rating and Higher Target
17d ago
DNLI
Denali Therapeutics: Avlayah Launch and Platform De-Risking Support Commercial Upside and Higher Valuation
Premium
Ratings
Denali Therapeutics: Avlayah Launch and Platform De-Risking Support Commercial Upside and Higher Valuation
17d ago
DNLI
Denali Therapeutics Gains FDA Approval for AVLAYAH Therapy
Premium
Company Announcements
Denali Therapeutics Gains FDA Approval for AVLAYAH Therapy
18d ago
8K
DNLI
Denali Therapeutics: Underappreciated Hunter Syndrome Launch and 2026 CNS Pipeline Catalysts Support Buy Rating
Premium
Ratings
Denali Therapeutics: Underappreciated Hunter Syndrome Launch and 2026 CNS Pipeline Catalysts Support Buy Rating
1M ago
DNLI
More DNLI News >

DNLI News on the Web

Lynx1 Capital Management LP Increases Stake in Korro Bio Inc
GuruFocus News
Neutral
Denali Stock Falls as Partner Takeda Ends Collaboration Deal
Zacks
Bullish
Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI) and Fennec Pharmaceuticals (FENC)
TipRanks News
Neutral
Denali Therapeutics price target raised to $34 from $32 at Baird
TipRanks News
Bullish
Denali Therapeutics: Differentiated PGRN Strategy and AVLAYAH Strength Support Buy Rating and Higher $39 Target Despite Biology Risks
TipRanks News
Bullish
Denali Therapeutics price target raised to $39 from $38 at BTIG
TipRanks News
Bullish
Denali Regains Full Control Of DNL593 As It Advances Toward Key 2026 Readout
rttnews
Bullish
Denali Therapeutics regains full rights to DNL593
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
DNLI
Sector Average
Media Buzz
This Week7 articles
Weekly Average9.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DNLI’s Media Buzz Sentiment?
7 articles about DNLI were published this week. In an average week, 9.5 articles are published.
    What is DNLI’s weekly average amount of articles?
    In an average week, 9.5 articles about DNLI are published.
      What is DNLI’s News Sentiment?
      100% of articles about DNLI were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week